Schilling, B., Gebhardt, C., & Hassel, J. C. (2019). First-line therapy-stratified survival in BRAF-mutant melanoma: A retrospective multicenter analysis. Cancer immunology immunotherapy, 68(5), . https://doi.org/10.1007/s00262-019-02311-1
Chicago-Zitierstil (17. Ausg.)Schilling, Bastian, Christoffer Gebhardt, und Jessica C. Hassel. "First-line Therapy-stratified Survival in BRAF-mutant Melanoma: A Retrospective Multicenter Analysis." Cancer Immunology Immunotherapy 68, no. 5 (2019). https://doi.org/10.1007/s00262-019-02311-1.
MLA-Zitierstil (9. Ausg.)Schilling, Bastian, et al. "First-line Therapy-stratified Survival in BRAF-mutant Melanoma: A Retrospective Multicenter Analysis." Cancer Immunology Immunotherapy, vol. 68, no. 5, 2019, https://doi.org/10.1007/s00262-019-02311-1.